OPIOIDS CONVERSION GUIDELINES 2007

Similar documents
Opioid Conversion Ratios - Guide to Practice 2010

Opioid Conversion Ratios - Guide to Practice 2013

Opioid Conversion Ratios - Guide to Practice 2013 Updated as Version 2 - November 2014

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

Pain Control Aims. General principles of pain control. Basic pharmacokinetics. Case history demo. Opioids renal failure John Welsh 8/4/2010

OPIOID CONVERSIONS. 2. Add a rescue doses (IR) of same opioid if possible should be~10 20% of total daily opioid dose

Narcotic drugs used for pain treatment Version 4.3

MUSC Opioid Analgesic Comparison Chart

Getting the best result from Opioid medicine. in the management of chronic pain

Quality Use of Medicines. Linda Graudins Senior Pharmacist, Medication Safety Alfred Health

The TIRF REMS Access program is a Food and Drug Administration (FDA) required risk management program

How To Take A Strong Opioid Painkiller

Policy for the issue of permits to prescribe Schedule 8 poisons

Health Service Clare Holland House, Palliative Care Service, Calvary Health Care ACT

Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients

Role of the Anaesthetist/Pain Consultant in Palliative Care Medicine

Abstral Prescriber and Pharmacist Guide

Use of opioids in Patients with Impaired Renal Function Dr Jane Neerkin, Dr Mary Brennan, Dr Humeira Jamal

The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool

END OF LIFE MEDICINES INFORMATION PACK

Information for Vermont Prescribers of Prescription Drugs (Long Form)

Palliative Care Pain Management

ABC of palliative care: Principles of palliative care and pain control

Opioids in Palliative Care- Patient Information Manual

Pain management. The WHO analgesic ladder

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

Blueprint for Prescriber Continuing Education Program

Fentanyl patches (Durogesic) for chronic pain

A Guide to pain relief medicines For patients receiving Palliative Care

Authorised Products Containing Substances Listed in Schedule 2 of. the Misuse of Drugs Regulations 1988, as amended

Good Practice Guidance: The safe management of controlled drugs in care homes

Equianalgesic Dosing of Opioids for Pain Management

How To Get A Tirf

WITHDRAWAL OF ANALGESIA AND SEDATION

SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC

Nurses Self Paced Learning Module on Pain Management

Cancer Pain Role Model Program Case Studies and Faculty Guides. Wisconsin Cancer Pain Initiative Madison, Wisconsin

A Healthesystems Clinical Analysis. Insidious Incrementalism of Opioid Use in Workers Compensation

Community Pharmacists in NHS Rotherham

Strong opioids (painkillers) in palliative care what you should know

POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics

Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction

West of Scotland Chronic Non Malignant Pain Opioid Prescribing Guideline

Your A-Z of Pain Relief A guide to pain relief medicines. We care, we discover, we teach

Therapeutic strategies for the treatment of pain

Pain Management Case Studies. Adapted from: IMPROVING END-OF-LIFE CARE A RESOURCE GUIDE FOR PHYSICIAN EDUCATION

Berkshire Healthcare NHS Foundation Trust Becky White CHS Pharmacist April 2013

Pharmaceutical care of people requiring palliative care Course activities

Hospice Palliative Care Program Symptom Guidelines. Principles Of Opioid Management

Fraud, Waste and Abuse

A practical guide to living with and after cancer. ControlliNG. cancer pain

Acute pain management for opioid tolerant patients CLASSIFICATION OF OPIOID TOLERANT PATIENTS

Pain Management in Palliative and Hospice Care

History of Malignant Pain: Treatment with Opioids. Dr. Kathleen M. Foley Pain, Opioids, and Addiction: An Urgent Problem for Doctors and Patients

SAFE PAIN MEDICATION PRESCRIBING GUIDELINES

Routes of Opioid Analgesic Therapy in the Management of Cancer Pain

1. Which of the following would NOT be an appropriate choice for postoperative pain. C. Oral oxycodone 5 mg po every 4 to 6 hours as needed for pain

Opioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist

Guide to the Pharmacological Management of End of Life (Terminal) Symptoms in Residential Aged Care Residents

UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE DEPARTMENT OF FAMILY MEDICINE PAIN MANAGEMENT GUIDELINES

Transdermal and Parenteral Fentanyl Dosage Calculations and Conversions

State of Louisiana. Department of Health and Hospitals Bureau of Health Services Financing

New England Pediatric Sickle Cell Consortium

Understanding Your Pain

Considerations when Using Controlled Substances to Treat Chronic Pain

Hospice & Palliative Care in Developing Countries

PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications

Care Guide: Cancer Pain

Drug Utilization Is On The Rise

! # # # %# # & # ( ) +,. / % # )., 0,, 5((/ + 6 0,67 8,+,, + 6,67, 7 6

A HISTORICAL PERSPECTIVE ON HUMAN ABUSE LIABILITY STUDIES. Donald R Jasinski, MD

Naloxone treatment of opioid overdose

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION

Pain Management After Knee Replacement

A Review of the Impacts of Opiate Use in Ontario: Summary Report

One example: Chapman and Huygens, 1988, British Journal of Addiction

Opioid toxicity and alternative opioids. Palliative care fixed resource session

Opioid Analgesics. Week 19

Gippsland Dual Diagnosis News

WHO Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence Dissemination, Implementation & Evaluation

Prescription Opioid Abuse: Translating Laboratory Findings to Clinical Practice

Drug Calculations. How to Solve Drug Calculations

Case Studies: Acute pain management in patients with opioid addiction. Shannon Levesque, PharmD Clinical Pharmacist

PALLIATIVE CARE PAIN MANAGEMENT AND NON-PAIN SYMPTOMS ONLY

Using Buprenorphine in an Opioid Treatment Program

October We hope that our tool will be a useful aid in your efforts to improve pain management in your setting. Sincerely,

Tramadol as an analgesic for mild to moderate cancer pain

Transcription:

Opioid analgesics vary in potency, side effect and pharmacokinetic profile. Therefore the Opioid Conversion Guidelines has been developed to assist when changing opioid drug therapy. When opioid rotating for intolerable side effects or inadequate analgesia, it is advisable to reduce the dose of the new opioid by 25-50% due to incomplete cross-tolerance. Please note that all conversions in these guidelines are a guide only as individual patients and drugs may react together in different ways. Oral to Oral Oral to Oral Ratio Example Oral to Oral Tramadol : 5 Oral 0mg = Oral Tramadol 50mg Oral to Oral Codeine : 8 Oral 7.5mg = Oral Codeine 60mg Oral to Oral Methadone? Complex pharmacology, discuss with Consultant. Dose requires to be titrated. Oral to Oral Oxycodone.5 : Oral 5mg = Oral Oxycodone 0mg Oral to Oral Hydromorphone Oral Dextropropoxyphene to Oral codeine 5 : Oral 5mg = Oral Hydromorphone mg : Digesic/Capadex (32.5/325mg) = Panadeine Forte (30mg/500mg) Oral to Subcutaneous Oral to Subcutaneous Ratio Example Oral to SC 2-3 : Oral 20-30mg = SC 0mg Oral Methadone to SC Methadone 2 : Oral Methadone 20mg = SC Methadone 0mg Oral Hydromorphone to SC Hydromorphone 2-3 : Oral Hydromorphone 2-3mg = SC Hydromorphone mg Oral Oxycodone to SC Oxycodone 2 : Oral Oxycodone 20mg = SC Oxycodone 0mg www.bethlehem.org.au Page of 5

Subcutaneous to Subcutaneous Subcutaneous to Subcutaneous Ratio Example SC to SC Hydromorphone 5 : SC 0mg = SC Hydromorphone 2mg SC Fentanyl to SC Sufentanil 0 : SC Fentanyl 00mcg = SC Sufentanil 0mcg SC to SC Fentanyl 70- SC 0mg = SC Fentanyl 00-50mcg 00 : SC to SC Oxycodone -.5 : SC 0-5mg = SC Oxycodone 0mg SC to SC Pethidine : 0 SC 0mg = SC Pethidine 00mg Subcutaneous to Other Opioid Conversions Subcutaneous to Other Ratio Example SC or SL Fentanyl to TTS Fentanyl : Fentanyl 600mcg/24 hr CSCI = Fentanyl patch 25 mcg/hr SC Sufentanil to SL Sufentanil : Sufentanil 0mcg CSCI = Sufentanil SL 0mcg SC to Epidural 0 : 00mg/24 hr CSCI = Epidural 0mg daily SC to IT 00 : SC to I/Ventricular 000 : 00mg/24 hr CSCI = IT mg daily 00mg/24 hr CSCI = Intraventricular 0. mg daily TTS = Transdermal Therapeutic System CSCI = Controlled Subcutaneous Infusion IT = Intrathecal Route www.bethlehem.org.au Page 2 of 5

Opioid Patch & Equivalent / Oxycodone Doses Strength TTS Medication Delivery Rate (micrograms /hour) SC (mg/24 hours) Oral (mg/24 hours) Oral Oxycodone (mg/24 hours) Durogesic Fentanyl 2 0-20 20-60 5-40 2 Durogesic Fentanyl 25 30-40 60-00 40-70 25 Durogesic Fentanyl 50 60-80 20-200 80-40 50 Durogesic Fentanyl 75 90-20 80-300 20-200 75 Durogesic Fentanyl 00 20-60 240-400 80-270 00 Norspan 5 Buprenorphine 5 9-3 5-0 Norspan 0 Buprenorphine 0 8-26 0-20 Norspan 20 Buprenorphine 20 36-53 25-40 After application of the fentanyl patch peak plasma levels are achieved ~ 24 hours (significant plasma levels occur in 2 to 6 hours). Buprenorphine patch takes 3 days to achieve its steady state. On removal serum elimination half lives are: fentanyl 5 20 hours: buprenorphine 2 hours. Oral opiates should not be started until at least 2 hours following removal of either patch (excluding breakthroughs). Regular oral analgesia needs to be continued for 2-24 hours after commencing either patch. FORMULA for calculating SUFENTANIL Break-Through Doses (BTD) for a given Fentanyl Patch. For a given Fentanyl Patch of x mcg/hr: BTD = x/5 micrograms of Sufentanil 2 hourly e.g. for Durogesic 25: BTD = 25/5 i.e 5 microgram Sufentanil 2 hourly Break-Through Doses should not exceed 40 micrograms Sufentanil Sufentanil is available as 250 mcg/5ml i.e. 50 mcg/ml www.bethlehem.org.au Page 3 of 5

Oral Analgesic Preparations Drug Trade Name Release Rate Usual Frequency Presentation Buprenorphine Temgesic Immediate Every 6-8 hours 200mcg tablets Dextropropoxyphene/ Paracetamol Digesic/Capadex / Paradex Immediate Every 6-8 hours 32.5mg/325mg tablets/capsules Fentanyl Actiq Immediate Every 2-3 hours Hydromorphone Dilaudid Immediate Every 2-3 hours Methadone Physeptone Immediate Every 2 hours MS Contin Slow Release Every 2 hours 200,400,600, 800mcg lozenges 2,4,8mg tabs, mg/ml mixt 0mg tablets, 5mg/ml mixt 5, 0, 5, 30, 60, 00, 200mg tab MS Contin Suspension Slow Release Every 2 hours 20, 30, 00mg sachet MS Mono Slow Release Every 24 hours Kapanol Slow Release Every 2-24 hours 30, 60, 90, 20mg capsule 0, 20, 50, 00mg capsule Anamorph Immediate Every 4-6 hours 30mg tablet Sevredol Immediate Every 4-6 hours 0, 20mg tablets Ordine Immediate Every 2-4 hours mg, 2mg, 5mg,0mg/ml mixture Oxycodone OxyContin Slow Release Every 2 hours 5, 0, 20, 40, 80mg tablet Endone Immediate Every 4-6 hours 5mg tablet OxyNorm Immediate Every 4-6 hours 5, 0, 20mg capsule. 5mg/5ml Liquid Tramadol Tramal/Zydol Immediate Every 4-6 hours 50mg tablet Tramal SR / Zydol SR Slow Release Every 2 hours 00mg, 50mg, 200mg tablet www.bethlehem.org.au Page 4 of 5

Reference/Supporting Framework: Analgesic Therapeutic Guidelines. Edition 4. Melbourne. 2002 Palliative Care Therapeutic Guidelines. Edition 2. Melbourne 2005. Australian Medicines Handbook. 2007 Product information. Mims [On-Line] Available: http://mims.hcn.net.au [2007,May] Narcotic analgesic, equianalgesic doses and pharmacokinetic comparison. Micromedex [On-Line] Available: http://micromedex.hcn.net.au [2007, May] www.bethlehem.org.au Page 5 of 5